C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors

Inflammation, obesity, and thrombosis

(2013) F. Samad et al.   BLOOD

The Complement Anaphylatoxin C5a Receptor Contributes to Obese Adipose Tissue Inflammation and Insulin Resistance

(2013) J. Phieler et al.   JOURNAL OF IMMUNOLOGY

The role of the complement system in metabolic organs and metabolic diseases

(2013) Julia Phieler et al.   SEMINARS IN IMMUNOLOGY

Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms

(2012) Danielle A.A. Hollman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Complement Diagnostics: Concepts, Indications, and Practical Guidelines

(2012) Bo Nilsson et al.   Clinical & Developmental Immunology

C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling

(2012) Junxian Lim et al.   FASEB JOURNAL

Recombinant Acylation Stimulating Protein Administration to C3−/− Mice Increases Insulin Resistance via Adipocyte Inflammatory Mechanisms

(2012) Mercedes Nancy Munkonda et al.   PLoS One

Complement C3 and cleavage products in cardiometabolic risk

(2011) Altan Onat et al.   CLINICA CHIMICA ACTA

Effect of weight loss on C3 and C4 components of complement in obese patients

(2011) Antonio Hernández-Mijares et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Hepatitis C Virus Proteins Inhibit C3 Complement Production

(2011) B. Mazumdar et al.   JOURNAL OF VIROLOGY

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation

(2009) Y. Mamane et al.   DIABETES

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population

(2009) Altan Onat et al.   METABOLISM-CLINICAL AND EXPERIMENTAL